[1]蒋健强,李晓娟,李拥军,等.白蛋白-胆红素评分在预测TACE治疗巨块型肝细胞癌后肝功能衰竭中的应用[J].介入放射学杂志,2023,32(01):55-58.
　JIANG Jianqiang,LI Xiaojuan,LI Yongjun,et al.The application of albumin-bilirubin score in predicting liver failure after transarterial chemoembolization for massive hepatocellular carcinoma [J].journal interventional radiology,2023,32(01):55-58.

点击复制

白蛋白-胆红素评分在预测TACE治疗巨块型肝细胞癌后肝功能衰竭中的应用()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］　陈　荔，滕皋军. TACE对原发性肝癌肝功能的损伤［J］. 东南大学学报（医学版），2012，31:643-647.

［2］　赵淑芬，刘卓环，黄江远，等. 中晚期肝癌患者肝动脉化疗栓塞术后肝功能代偿不全影响因素分析［J］. 内科急危重症杂志，2019，25:19-20.

［3］　周　雄，邓　开，陈　俊，等. 影响TACE治疗原发性肝癌后肝功能损伤的相关因素研究［J］. 实用癌症杂志，2016，31:991-993.

［4］　Miksad RA, Ogasawara S, Xia F, et al. Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study［J］. BMC Cancer, 2019, 19:795.

［5］　Park KH, Kim JH, Choe WH, et al . Risk factors for liver function deterioration after transarterial chemoembolization refractoriness in Child-Pugh class a hepatocellular carcinoma patients［J］. Korean J Gastroenterol, 2020, 75:147-156.

［6］　俞　婷，俞　谦，欧希龙，等. 原发性肝癌肝动脉化疗栓塞后严重肝功能失代偿的相关因素分析［J］. 现代医学，2009，37:20-23.

［7］　中国医师协会介入医师分会. 中国肝细胞癌经动脉化疗栓塞治疗临床实践指南［J］. 中华放射学杂志，2019，53：246-255.

［8］　Chan AWH, Leung HHW, Chong CCN, et al. Validating the ALBI grade: its current and future use in HCC prognostication［J］. J Hepatol, 2017, 66:661-663.

［9］　Rahbari NN, Gardon OJ, Padbuy R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery（ISGLS）［J］. Surgery, 2011, 149：713-724.

［10］张长坤，张龙辉，王　东，等. 术前肝功能Child-Pugh评分与白蛋白-胆红素评分对肝癌患者肝切除术后肝衰竭和预后的预测价值［J］. 中华消化外科杂志，2018，17:474-482.

［11］曾勇超，戴朝六，卜献民，等. ALBI评分与Child-Pugh评分对肝癌肝切除术后肝衰竭预测的比较［J］. 中华普通外科杂志，2019，34:649-651.

［12］谢浩荣，王　恺，周　杰. 白蛋白-胆红素评分与Child-Pugh评分预测肝癌患者术后肝功能衰竭的效果比较［J］. 中华肝胆外科杂志，2018，24:173-178.

［13］Hiraoka A, Kumada T, Michitaka K, et al. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma［J］. J Gastroenterol Hepatol, 2016, 31:1031-1036.

［14］孙　玉，张洪海，生守鹏，等. 白蛋白-胆红素分级在早期肝细胞癌射频消融中的预后意义［J］. 介入放射学杂志，2021，30:502-507.

［15］ Robald J, Wang Q, Choi SS, et al. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt （TIPS）creation［J］. Diagn Interv Imaging, 2018, 99:163-168.

［16］ Kudo M. Recent advances in systemic therapy for hepatocellular carcinoma in an aging society: 2020 update［J］. Liver Cancer, 2020, 9:640-662.

相似文献/References:

[1]王有枝,李彦豪,梅雀林,等.原发性肝癌肝动脉化疗栓塞术后继发溶血性尿毒综合征3例并文献复习[J].介入放射学杂志,2016,(06):543.
　WANG You-zhi,LI Yan-hao,MEI Que-lin,et al.Secondary hemolytic uremic syndrome occurring after transcatheter arterial chemoembolization for primary hepatocellular carcinoma: report of 3 cases with literature review [J].journal interventional radiology,2016,(01):543.
[2]刘　晟,周平盛,沈　强,等.超声引导下微波消融术治疗特殊部位与非特殊部位单发肝细胞癌的疗效对比[J].介入放射学杂志,2023,32(01):36.
　LIU Sheng,ZHOU Pingsheng,SHEN Qiang,et al.Ultrasound-guided microwave ablation for the treatment of single hepatocellular carcinoma located at specific area and at non-specific area: comparison of clinical efficacy[J].journal interventional radiology,2023,32(01):36.
[3]王　曦,冯　苏,李　红,等.免疫检查点抑制剂联合TACE在肝癌治疗中的研究进展[J].介入放射学杂志,2023,32(01):90.
　WANG Xi,FENG Su,LI Hong,et al.Research progress in immune checkpoint inhibitors combined with TACE for the treatment of hepatocellular carcinoma[J].journal interventional radiology,2023,32(01):90.